The risk of long COVID was two to three times higher after the initial infection (14.8%) than after first (5.8%) or second (5.3%) reinfections.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
Data show that people taking immunosuppressive drugs, including cancer patients, are not at higher risk.
By the end of today 2.6 million young American children will have gotten their first shot.
For the 4th week in a row, the rate of new global COVID-19 cases rose, led by surges in Europe.
New research from the Mayo Clinic shows monoclonal antibodies reduce the risk of hospitalization 77% in 1,395 patients who had breakthrough COVID-19 infections. The research was published yesterday in the Journal of Infectious Diseases.
Pfizer has applied for emergency use authorization from the FDA for Paxlovid, its COVID-19 drug.
More than 95% of the state's available inpatient hospital beds are filled with patients.
Of the patients taking fluoxetine (Prozac), 9.8% died, versus 13.3% of control patients, a 28% reduction.
An automated text messaging system for adult COVID-19 outpatients developed at Penn Medicine saved two lives a week during the first US pandemic surge, and users were 68% less likely than controls to die, finds a study today in the Annals of Internal Medicine.
Women need resources to navigate this uncertain time, the authors say.
About 65% of Austrians are vaccinated, a low level for Western Europe.
